Oragenics, Inc.
General ticker "OGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $8.4M (TTM average)
Oragenics, Inc. does not follow the US Stock Market performance with the rate: -24.5%.
Estimated limits based on current volatility of 3.0%: low 0.83$, high 0.89$
Factors to consider:
- Total employees count: 3 (-40.0%) as of 2024
- Top business risk factors: Operational and conduct risks, Labor/talent shortage/retention, Market competition, Product ineffectiveness risk, Intellectual property risks
- Current price 84.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.34$, 19.99$]
- 2025-12-31 to 2026-12-31 estimated range: [2.82$, 10.35$]
Financial Metrics affecting the OGEN estimates:
- Negative: with PPE of -6.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -11.30 <= 0.33
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Interest expense per share per price, % of 0.04 <= 0.79
- Negative: negative Net income
- Negative: Shareholder equity ratio, % of -14.39 <= 18.93
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Negative: -0.75 < Inventory ratio change, % of 0
Short-term OGEN quotes
Long-term OGEN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $14.42MM | $20.90MM | $10.56MM |
| Operating Income | $-14.42MM | $-20.90MM | $-10.56MM |
| Non-Operating Income | $0.13MM | $0.25MM | $-0.01MM |
| Interest Expense | $0.02MM | $0.00MM | $0.03MM |
| R&D Expense | $10.07MM | $15.49MM | $4.11MM |
| Income(Loss) | $-14.29MM | $-20.66MM | $-10.57MM |
| Profit(Loss)* | $-14.29MM | $-20.66MM | $-10.57MM |
| Stockholders Equity | $13.01MM | $3.17MM | $-0.21MM |
| Assets | $14.76MM | $4.97MM | $1.47MM |
| Operating Cash Flow | $-15.23MM | $-7.29MM | $-8.60MM |
| Capital expenditure | $0.13MM | $1.00MM | $0.00MM |
| Investing Cash Flow | $-0.12MM | $-0.94MM | $0.00MM |
| Financing Cash Flow | $-0.49MM | $0.28MM | $5.98MM |
| Earnings Per Share** | $-7.11 | $-9.18 | $-1.60 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.